A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full application. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: November 30 - December 1, 2015

Wan Lam, PhD (Chair) BC Cancer Agency
Vancouver, BC
Jim Davie, Phd University of Manitoba
Winnipeg, MB
Robert Day, PhD  University of Sherbrooke
Sherbrooke, QC
Harriet Feilotter, PhD Queen’s University
Kingston, ON
Michael Hendzel, PhD  University of Alberta
Edmonton, AB
Annie Huang, MD/PhD The Hospital for Sick Children
Toronto, ON
Maja Krajinovic, MD/PhD University of Montreal
Montreal, QC
William Lockwood, PhD BC Cancer Agency
Vancouver, BC
Julian Lum, PhD  BC Cancer Agency
Vancouver, BC
Sylvie Mader, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Christopher Mueller, PhD Queen’s University
Kingston, ON
Robert Sladek, MD McGill University
Montreal, QC
Christian Steidl, MD BC Cancer Research Centre
Vancouver, BC
Steve Bilodeau, PhD (Scientific Officer) Centre Hospitalier Universitaire de Quebec (CHUQ)
Quebec City, QC
Troy Harkness, PhD (Scientific Officer) University of Saskatchewan
Saskatoon, SK

 Other members to be confirmed.

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: December 2-3, 2015

John White, PhD (Chair) McGill University
Montreal, QC
Deborah Anderson, PhD University of Saskatchewan
Saskatoon, SK
David Brindley, PhD University of Alberta
Edmonton, AB
Jocelyn Côté, PhD University of Ottawa
Ottawa, ON
Daniel Durocher, PhD Lunenfeld-Tanenbaum Research Institute
Toronto, ON
Imed Gallouzi, PhD  McGill University
Montreal, QC
Russell Jones, PhD McGill University
Montreal, QC 
Murray Junop, PhD Western University
London, ON
Benjamin Kwok, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Susan Lees-Miller, PhD University of Calgary
Calgary, AB
C Jane McGlade, PhD The Hospital for Sick Children
Toronto, ON
Janusz Rak, MD/PhD Research Institute of the McGill University Health Centre
Montreal, QC
Igor Stagljar, PhD University of Toronto
Toronto, ON
Uri Tabori, MD The Hospital for Sick Children
Toronto, ON
Leonardo Salmena, PhD (Scientific Officer) University of Toronto
Toronto, ON 
Jim Uniacke, PhD (Scientific Officer) University of Guelph
Guelph, ON

 Other members to be confirmed.

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: December 1-2, 2015

Michael Patterson, PhD (Chair) McMaster University
Hamilton, ON
Daniel Côté, PhD  Laval University
Quebec City, QC 
Marianna Koritzinsky, PhD Princess Margaret Cancer Centre
Toronto, ON
Piotr Kozlowski, PhD University of British Columbia
Vancouver, BC
Mark Niedre, PhD  Northeastern University
Boston, MA
Brian Nieman, PhD  The Hospital for Sick Children
Toronto, ON 
Christopher Phenix, PhD  Thunder Bay Regional Research Institute
Thunder Bay, ON 
Frank Wuest, PhD University of Alberta
Edmonton, AB
Rebecca Thornhill, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Aaron Ward, PhD (Scientific Officer) London Health Sciences Centre
London, ON

 Other members to be confirmed.

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: December 3-4, 2015

Ben Alman, MD (Chair) Duke University
Durham, NC
Laurie Ailles, PhD Princess Margaret Cancer Centre
Toronto, ON
David Brooks, PhD Princess Margaret Cancer Centre
Toronto, ON
Javier Di Noia, PhD IRCM - Institut de Recherches Cliniques de Montréal
Montreal, QC
Sam Kung, PhD University of Manitoba
Winnipeg, MB
Andrew Makrigiannis, PhD University of Ottawa
Ottawa, ON
Douglas Mahoney, PhD University of Calgary
Calgary, AB
Mark Minden, MD/PhD  Princess Margaret Cancer Centre
Toronto, ON
Lisa Porter, PhD University of Windsor
Windsor, ON
Josie Ursini-Siegel, PhD Lady Davis Institute
Montreal, QC
André Veillette, MD IRCM - Institut de Recherches Cliniques de Montréal
Montreal, QC
Heather Melichar, PhD (Scientific Officer) Hopital Maisonneuve-Rosemont
Montreal, QC

 Other members to be confirmed.

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: December 8-9, 2015

Michel Roberge, PhD (Chair) University of British Columbia
Vancouver, BC
Robert Britton, PhD Simon Fraser University
Burnaby, BC
Daniel De Carvalho, PhD Princess Margaret Cancer Centre
Toronto, ON
Mark Glover, PhD University of Alberta
Edmonton, AB
Fei-Fei Liu, MD Princess Margaret Cancer Centre
Toronto, ON
Christopher Maxwell, PhD University of British Columbia
Vancouver, BC
Sylvain Meloche, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Alain Nepveu, PhD  McGill University
Montreal, QC 
Kevin Petrecca, MD/PhD  McGill University
Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta
Edmonton, AB
Murray Webb, PhD The Centre for Drug Research and Development (CDRD)
Vancouver, BC
Philippe Bedard, MD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON

 Other members to be confirmed.

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: December 7, 2015

Patricia Parker, PhD (Chair) Memorial Sloan-Kettering Cancer Center
New York, NY
Andrea Cherrington, MD  University of Alabama at Birmingham
Birmingham, AL
Hugh Davies, PhD  University of British Columbia
Vancouver, BC 
Igor Karp, PhD Western University
London, ON
Karen Kopciuk, PhD  Alberta Health Services
Calgary, AB 
Jonathan Sussman, MD Juravinski Cancer Centre
Hamilton, ON
Thomas Tenkate, PhD Ryerson University
Toronto, ON
Alice Wei, MD  Princess Margaret Cancer Centre
Toronto, ON
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS
Ryan Kennedy, PhD (Scientific Officer) Johns Hopkins University
Baltimore, MD

 Other members to be confirmed.

Impact Grant panel

LOI review teleconference: June 23, 2015
Panel meeting: November 19, 2015

John Bell, PhD (Co-Chair) Ottawa Hospital Research Institute
Ottawa, ON 
Michael Brundage, MD
(Co-Chair)
Kingston General Hospital
Kingston, ON
Samuel Aparicio, PhD BC Cancer Research Centre
Vancouver, BC
Marcel Bally, PhD BC Cancer Agency
Vancouver, BC
Mick Bhatia, PhD McMaster University
Hamilton, ON
Deborah Bowen, PhD University of Washington
Seattle, WA
Shoukat Dedhar, PhD BC Cancer Agency
Vancouver, BC
Steven Gallinger, MD  Toronto General Hospital
Toronto, ON 
Peter Greer, PhD Queen’s University
Kingston, ON
Cynthia Hawkins, MD/PhD  The Hospital for Sick Children
Toronto, ON
Nada Jabado, MD/PhD McGill University
Montreal, QC
Rama Khokha, PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Nathalie Labrecque, PhD University of Montreal
Montreal, QC
Calum MacAulay, PhD  BC Cancer Agency
Vancouver, BC 
Warren Mason, MD/PhD Princess Margaret Cancer Centre
Toronto, ON
Matthew Parliament, MD  Cross Cancer Institute
Edmonton, AB
Claude Perreault, MD  IRIC
Montreal, QC 
Janet Rossant, PhD The Hospital for Sick Children
Toronto, ON
Gurmit Singh, PhD  McMaster University
Hamilton, ON 
Lillian Siu, MD Princess Margaret Cancer Centre
Toronto, ON
Nahum Sonenberg, PhD McGill University
Montreal, QC
John Spinelli, PhD BC Cancer Agency
Vancouver, BC
Lillian Sung, MD/PhD The Hospital for Sick Children
Toronto, ON
Scott Tyldesley, MD BC Cancer Agency
Vancouver, BC
Jeffrey Wrana, PhD Mount Sinai Hospital
Toronto, ON
Camilla Zimmermann, MD/PhD Princess Margaret Cancer Centre
Toronto, ON

Prevention Research Grant panel

LOI review teleconference: March 31, 2015
Panel meeting: September 30, 2015

Eduardo Franco, MPH/PhD(Chair)  McGill University
Montreal, QC
Irene Andrulis, PhD  Mount Sinai Hospital
Toronto, ON 
*Sunday Azagba, PhD University of Waterloo
Waterloo, ON
Michael Chaiton, PhD University of Toronto
Toronto, ON
*Claire de Oliveira, PhD Centre for Addiction and Mental Health
Toronto, ON
Walter Gotlieb, MD/PhD  Jewish General Hospital
Montreal, QC 
*Melissa Henry, PhD Jewish General Hospital
Montreal, QC
Nancy Kreiger, MPH/PhD Cancer Care Ontario
Toronto, ON
Steve Manske, EdD University of Waterloo
Waterloo, ON
Anthony Miller, MD University of Toronto
Toronto, ON
*Roger Moorehead, PhD University of Guelph
Guelph, ON
Paola Muti, MD McMaster University
Hamilton, ON
Gina Ogilvie, MD/PhD University of British Columbia
Vancouver, BC
Tracy Orleans, PhD Robert Wood Johnson Foundation
Princeton, NJ
*Harriet Richardson, PhD Queen’s University
Kingston, ON
Marie-Claude Rousseau, PhD  Institut national de la recherche scientifique
Laval, QC 
Jacques Simard, PhD  Centre de recherche du CHU de Québec
Québec, QC 
Ingeborg Zehbe, PhD  Thunder Bay Regional Research Institute
Thunder Bay, ON
Victoria Arrandale, PhD (Scientific Officer) Cancer Care Ontario
Toronto, ON
Rebecca Haines-Saah, PhD (Scientific Officer) Simon Fraser University
Vancouver, BC
Janice Hodgson (Community Representative)  Canadian Cancer Society - Ontario Division 
Nancy Yarmel (Community Representative) Canadian Cancer Society - Ontario Division

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014
Panel meeting: September 30, 2014

Richard (Dick) Clayton, PhD (Chair)  University of Kentucky
Lexington, KY, USA
Tracie Barnett, PhD  University of Montreal
Montreal, QC 
Ulrike (Uli) Boehmer, PhD  Boston University
Boston, MA, USA 
Anne Leis, PhD University of Saskatchewan
Saskatoon, SK
S. Elizabeth McGregor, PhD  Alberta Health Services
Calgary, AB 
Annette Schultz, PhD/RN  University of Manitoba
Winnipeg, MB 
Siobhan Sutcliffe, PhD  Washington University School of Medicine
St. Louis, MO, USA
Shelley Tworoger, PhD  Harvard University
Boston, MA, USA 
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS 
Sylvie Poissant (End User)  Canadian Cancer Society - Quebec Division
Montreal, QC
Anne McTiernan-Gamble (End User)  Canadian Cancer Society - New Brunswick Division
Saint John, NB
Julie Stratton (End User)  Region of Peel, Public Health
Mississauga, ON

Career Development Awards in Prevention panel

Panel meeting: June 18, 2015

Julia Knight, PhD (Chair)  Mount Sinai Hospital
Toronto, ON
Joan L. Bottorff, PhD/RN University of British Columbia Okanagan
Kelowna, BC
Katherine Frohlich, PhD University of Montreal
Montreal, QC
Shelley Harris, PhD CancerCare Ontario
Toronto, ON
Salaheddin Mahmud, PhD University of Manitoba
Winnipeg, MB
Jennifer Yessis, PhD  University of Waterloo
Waterloo, ON

Quality of Life Grant panel

LOI review teleconference: September 18, 2015
Panel meeting: January 14, 2016

Jamie Studts, PhD 
(Chair)
University of Kentucky
Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre
Toronto, ON
Cristina Caperchione, PhD University of British Columbia (Okanagan)
Kelowna, BC
Anees Chagpar, MD Yale University
New Haven, CT
Kelvin Chan, MD Sunnybrook Research Institute
Toronto, ON 
S. Robin Cohen, PhD McGill University
Montreal, QC 
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
David Eisenstat, MD University of Alberta
Edmonton, AB 
Sophie Lebel, PhD University of Ottawa
Ottawa, ON
Christopher Longo, PhD McMaster University
Hamilton, ON
Donald Mabbott, PhD The Hospital for Sick Children
Toronto, ON
Christine Maheu, PhD McGill University
Montreal, QC 
Suzanne O’Neill, PhD Georgetown University
Washington, DC
Dean Regier, PhD  BC Cancer Agency
Vancouver, BC 
Tara Schapmire, PhD  University of Louisville
Louisville, KY
Allen Sherman, PhD  University of Arkansas
Little Rock, AR 
Marcy Winget, PhD Stanford University
Stanford, CA 
Rebecca Wong, MD  Princess Margaret Cancer Centre
Toronto, ON
James Wright, PhD Juravinski Cancer Centre
Hamilton, ON 
Eitan Amir, PhD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON 
LaurenWalker, PhD (Scientific Officer) Tom Baker Cancer Centre
Calgary, AB
Other members to be confirmed.

Knowledge to Action Grant panel

Panel meeting: May 14, 2015

David Chambers, PhD (Chair)  National Cancer Institute
Rockville, MD
Lisa Barbera, PhD  Sunnybrook Research Institute
Toronto, ON 
Jamie Brehaut, PhD  Ottawa Hospital Research Institute
Ottawa, ON 
Nicole Culos-Reed, PhD University of Calgary
Calgary, AB 
Arminee Kazanjian, PhD  University of British Columbia
Vancouver, BC 
Rodger Kessler, PhD University of Vermont
Burlington, VT
Anita Kothari, PhD  Western University
London, ON
Monika Krzyzanowska, MD/MPH  Princess Margaret Cancer Centre
Toronto, ON 
Martine Puts, PhD University of Toronto
Toronto, ON 
Barbara Riley, PhD University of Waterloo
Waterloo, ON
Robert Schwartz, PhD  University of Toronto
Toronto, ON
Marko Simunovic, MD/MPH Juravinski Caner Clinic
Hamilton, ON
Jennifer Brunet, PhD (Scientific Officer)  University of Ottawa
Ottawa, ON 
Shannon Sibbald, PhD (Scientific Officer) Western University
London, ON
Stephen Ng (Community Representative) Canadian Cancer Society - BC/Yukon Division
Sean Nurmsoo (Community Representative) Canadian Cancer Society - Nova Scotia Division

Last modified on: August 27, 2015